Literature DB >> 8145064

Partial characterization of glioma-derived growth factor 2: a novel mitogenic activity from human cell line D-54 MG.

E Lyon1, G Y Gillespie.   

Abstract

We have shown that several human malignant glioma cell lines are stimulated by bacterial lipopolysaccharide (E. coli 0111:B4, 1 microgram/ml) to produce a high molecular weight (> 200 kD) growth activity for BALB 3T3, clone A31 cells. This glioma-derived growth factor (GDGF-2) acts like a 'competence' factor. Malignant glioma cell line D-54 MG constitutively produced GDGF-2, which we have partially characterized from serum-free conditioned culture medium. GDGF-2 is resistant to heat (100 degrees C, 5 min), acidic (pH 2, 2 hr) or reducing (0.5 M 2 ME, 30 min) conditions as well as exposure to RNases; however, it is sensitive to > 4 freeze-thaw cycles, alkaline (pH 11, 2 hr) conditions or pre-treatment with proteolytic enzymes. GDGF-2 had a pl of 6.8 determined by preparative isoelectric focusing, bound to DEAE, with elution at 35 and 185 mM NaCl and at 43% acetonitrile from a C4 reversed phase column. GDGF-2 activity was not neutralized by antibodies to TGF alpha, TGF beta, PDGF, VEGF or TNF alpha indicating that it is not immunochemically related to these growth factors. However GDGF-2 co-chromatographed on Superose 12 HPLC (250 x 9 mm; 5% isopropanol, 6 mM CHAPS in PBS) with a substance that suppressed growth of mink lung epithelial cells (Mv1Lu), but not BALB 3T3 cells, and could be neutralized by anti-TGF beta antibodies. GDGF-2 activity eluted from heparin columns in 0.6 M NaCl; thus, it is not a heparin binding growth factor. D-54 MG cell line produced alpha 2-macroglobulin (alpha 2M), which is known to bind TGF beta; however, immunoprecipitation of alpha 2M did not deplete TGF beta or GDGF-2 activity. Further, neither GDGF-2 or TGF beta can be dissociated into lower molecular weight active components by chromatography in high salt (2 M NaCl) or 2-ME (0.5 M). GDGF-2 may be a novel autocrine or paracrine mitogen, stimulating mitotic division or interfering with normal cell growth regulation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8145064     DOI: 10.1007/bf01050212

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  30 in total

1.  Transforming growth factor-beta complexes with thrombospondin.

Authors:  J E Murphy-Ullrich; S Schultz-Cherry; M Höök
Journal:  Mol Biol Cell       Date:  1992-02       Impact factor: 4.138

2.  Type beta transforming growth factor controls the adipogenic differentiation of 3T3 fibroblasts.

Authors:  R A Ignotz; J Massagué
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

3.  Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin.

Authors:  M D O'Connor-McCourt; L M Wakefield
Journal:  J Biol Chem       Date:  1987-10-15       Impact factor: 5.157

4.  The TGF-beta family of growth and differentiation factors.

Authors:  J Massagué
Journal:  Cell       Date:  1987-05-22       Impact factor: 41.582

5.  Enhanced ELISA: how to measure less than 10 picograms of a specific protein (immunoglobulin) in less than 8 hours.

Authors:  E Macy; M Kemeny; A Saxon
Journal:  FASEB J       Date:  1988-11       Impact factor: 5.191

6.  L-428 nodular sclerosing Hodgkin's cell secretes a unique transforming growth factor-beta active at physiologic pH.

Authors:  S R Newcom; M E Kadin; A A Ansari; V Diehl
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

7.  Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix.

Authors:  E A Jaffe; J T Ruggiero; L K Leung; M J Doyle; P J McKeown-Longo; D F Mosher
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

8.  Isolation and partial purification of growth factors with TGF-like activity from human malignant gliomas.

Authors:  J T Rutka; M L Rosenblum; R Stern; H J Ralston; D Dougherty; J Giblin; S DeArmond
Journal:  J Neurosurg       Date:  1989-12       Impact factor: 5.115

9.  A glioma-derived PDGF A chain homodimer has different functional activities from a PDGF AB heterodimer purified from human platelets.

Authors:  M Nistér; A Hammacher; K Mellström; A Siegbahn; L Rönnstrand; B Westermark; C H Heldin
Journal:  Cell       Date:  1988-03-25       Impact factor: 41.582

10.  Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta.

Authors:  J L Andres; K Stanley; S Cheifetz; J Massagué
Journal:  J Cell Biol       Date:  1989-12       Impact factor: 10.539

View more
  1 in total

1.  Cell kinetic analysis in recurrent neuro-epithelial tumours.

Authors:  E Gömöri; I Mészáros; G Méhes; T Dóczi; L Pajor
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.